Next Tuesday’s election will decide a lot – including 435 U.S. Representatives, 35 U.S. Senators, 36 Governors, and more than 6,000 state legislators. Control of the U.S. House of Representatives and U.S. Senate hang in the balance.
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
Comments to Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than January 1, 2023.
One month ago, NACDS RxIMPACT said it would push for congressional pharmacy tours with only 25 in-district workdays left in July and August -- and it did just that.
Momentum continues to build for bipartisan legislation that would help protect Americans’ access to pharmacist care as NACDS members urge Congressional action during the 2022 NACDS Total Store Expo in Boston.
Last week, NACDS took issue with an op-ed in The Wall Street Journal titled, “In Defense of Pharmacy Benefit Managers (PBMs),” which asserted that “swarms of drug-company lobbyists appear to have united both parties in opposition to [PBMs]” and that PBMs – unreasonably – “are taking the blame for high drug prices.”
With only 25 in-district work days left in July and August, the pharmacy community continues its great work promoting pro-patient, pro-pharmacy policy priorities to Members of Congress and their staff via the NACDS RxIMPACT Pharmacy Tour Program.
On Wednesday, Drug Store News published an opinion piece by NACDS President & CEO Steven C. Anderson.
Diverse NACDS-backed provisions would enhance patients’ access to OTC hearing aids and to biosimilar and generic medications, and would maintain flexibility in drug disposal options.
